Latest News and Press Releases
Want to stay updated on the latest news?
-
GREAT NECK, N.Y., March 11, 2022 (GLOBE NEWSWIRE) -- Manhattan Bridge Capital, Inc. (NASDAQ: LOAN) announced today that net income for the year ended December 31, 2021 was approximately $4,423,000,...
-
MARKHAM, Ontario, March 11, 2022 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. ("Sienna" or the "Company") (TSX:SIA) announced today that it has entered into an agreement to acquire a 50% ownership...
-
PARAMOUNT, Calif., March 11, 2022 (GLOBE NEWSWIRE) -- Tattooed Chef, Inc. (Nasdaq: TTCF) (“Tattooed Chef” or the “Company”), a leader in plant based foods, today announced its participation in the...
-
NEW YORK, 11 mars 2022 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS - Nasdaq: CLLS), société de biotechnologie de stade clinique, qui utilise sa technologie pionnière d'édition de génome...
-
NEW YORK, March 11, 2022 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to...
-
TORONTO, March 11, 2022 (GLOBE NEWSWIRE) -- Barrick Gold Corporation (“Barrick”) (NYSE:GOLD)(TSX:ABX) announced today that following the completion by Reunion Gold Corporation (“Reunion”) of its...
-
On March 11 2022, the Financial Supervisory Authority of Norway (Finanstilsynet) approved a prospectus prepared by Golar LNG Limited (“Golar”) in connection with an application for listing of the bond...
-
Monthly information regarding the total number of voting rights and total number of shares of the Company as of February 28, 2022 (Article 223-16 of the General Regulations of the Autorité des...
-
PARAMOUNT, Calif., March 11, 2022 (GLOBE NEWSWIRE) -- Tattooed Chef, Inc. (Nasdaq: TTCF) (“Tattooed Chef” or the “Company”), a leader in plant based foods, today announced that it will restate prior...
-
CAMBRIDGE, Mass., March 11, 2022 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) announced the company will present new Alzheimer’s disease research, as well as data for ADUHELM® (aducanumab-avwa)...